Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
130 participants
INTERVENTIONAL
2010-09-30
2011-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Diabetes Toolkit at Discharge
NCT05663931
Evaluation of a Stepped Care Approach to Manage Depression in Diabetes
NCT01812291
Cognitive Behavioral Therapy for Adherence in Patients With Type 2 Diabetes
NCT04214600
Enhancing Diabetes Management Approaches for Patients With Uncontrolled Diabetes
NCT05912647
Continuous Glucose Monitoring, Contingency Management, and Motivational Interviewing for Patients With Type 2 Diabetes in Kansas City
NCT06374186
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Standard therapy: Nurses distribute a education pamphlet on diabetes.
Pharmacist Counseling includes but is not limited to:
* Reviewing and explaining their medications (dosing, side effects, route)
* Reviewing symptoms and complications of hyper and hypoglycemia
* Defining glycemic \& non-glycemic goal levels
* Explaining the importance of compliance with medications \& appointments
* Educating on the basics of nutrition and physical activity
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pharmacist Counseling
Pharmacist Counseling includes but is not limited to:
Reviewing and explaining their medications (dosing, side effects, route) Reviewing symptoms and complications of hyper and hypoglycemia Defining glycemic \& non-glycemic goal levels Explaining the importance of compliance with medications \& appointments Educating on the basics of nutrition and physical activity
Pharmacist Counseling
Pharmacist Counseling includes but is not limited to:
Reviewing and explaining their medications (dosing, side effects, route) Reviewing symptoms and complications of hyper and hypoglycemia Defining glycemic \& non-glycemic goal levels Explaining the importance of compliance with medications \& appointments Educating on the basics of nutrition and physical activity
Standard therapy
Standard therapy: Nurses distribute a education pamphlet on diabetes
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pharmacist Counseling
Pharmacist Counseling includes but is not limited to:
Reviewing and explaining their medications (dosing, side effects, route) Reviewing symptoms and complications of hyper and hypoglycemia Defining glycemic \& non-glycemic goal levels Explaining the importance of compliance with medications \& appointments Educating on the basics of nutrition and physical activity
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18 to 85 years of age
* Historical diagnosis of type 2 diabetes mellitus greater than one year
* HbA1c concentration ≥ 8%
* Discharged from general medicine unit of John H. Stroger Jr, Hospital of Cook County
* Patient with provider and prescriptions filled within CCHS
Exclusion Criteria
* Pregnancy
* Major illness or debility, that prohibits the subject from participating in the study
* History of any hemoglobinopathy that may affect determination of HbA1c
* Non-English speaking patients
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cook County Health
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Leon Fogelfeld MD
Chair, Division of Endocrinology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Leon Fogelfeld, M.D.
Role: PRINCIPAL_INVESTIGATOR
John H. Stroger Hospital of Cook County, Division of Endocrinology
Mansi Shah, PharmD
Role: PRINCIPAL_INVESTIGATOR
John H. Stroger Hospital of Cook County, Department of Pharmacy
CaTanya Norwood, R.PH
Role: PRINCIPAL_INVESTIGATOR
John H. Stroger Hospital of Cook County, Department of Pharmacy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
John H. Stroger Jr. Hospital of Cook County
Chicago, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB #10-165
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.